Meeder Asset Management Inc Zynerba Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$3.31 - $6.54 $8,069 - $15,944	-2,438 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.9 - $6.16 $7,070 - $15,018	2,438 New	2,438 $9,000
Q4 2019 Feb 13, 2020	SELL	$5.61 - $8.57 $7,102 - $10,849	-1,266 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$7.56 - $15.44 $9,570 - $19,547	1,266 New	1,266 $9,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.